24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BioCanCell
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:41
Five desalination plants are struggling. Israel won't say how it is making up the difference
12:18
Zuckerberg rejects calls for AI industry-wide slowdown
12:09
Israel's 1.5% inflation rate may be more mirage than reality
11:05
Israel spent $75.7 billion on the war through 2025, with costs set to persist for years
More stories
Buzz
Most popular
Daily
Weekly
1
Buildots raises $130 million at nearly $1 billion valuation as AI boom drives data center construction
2
Oracle’s AI transformation gets more expensive as layoffs continue
3
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
4
OpenAI acquires Israeli-founded camera startup Glass Imaging for over $300 million
5
Oracle begins another round of layoffs as $2.8 billion restructuring plan expands
More news
BioCanCell
9 stories about BioCanCell
Anchiano Therapeutics Schedules TASE Delisting
14.03.19
|
Lilach Baumer
Based in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer
Cancer Treatment Company Anchiano Therapeutics Wants to List on Nasdaq
09.01.19
|
Lilach Baumer
The company formerly known as BioCanCell submitted a prospectus to the SEC on Monday, with Oppenheimer & Co. as the sole underwriter
Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week
04.07.18
|
CTech
Clal Biotechnology Industries is an Israel-based life sciences investment company
Cancer Treatment Company BioCanCell Raises $22.9 Million in Private Placement
02.07.18
|
CTech
The company announced the issuance of 5.9 million new shares in April
CTech’s Monday Roundup of Israeli Tech News
23.04.18
|
CTech
Israeli satellite operator Spacecom bundled in a bid for Tel Aviv real estate. eBay Israel general manager Yuval Matalon steps down
Attempting to Delist, Cancer Treatment Company BioCanCell Issues New Shares
23.04.18
|
Dror Reich
The company diluted existing investors that opposed its plans to delist from the Tel Aviv Stock Exchange
CTech’s Daily Israeli Tech News Roundup
23.01.18
|
CTech
BioCanCell raises $25 million. Israel lags behind most developed countries on the Inclusive Development Index. Activist investor Jana Partners takes stake in Teva
Pharma Company BioCanCell Raises $25 million, Plans to Go Public in the U.S.
23.01.18
|
Asaf Shalev
The company said it will use the funding for clinical trials of BC-819, a drug being designed to treat early stage bladder cancer
Cancer Treatment Company Negotiating $20-25 Million Capital Injection
29.10.17
|
Lilach Baumer
The potential investors condition the investment on delisting BioCanCell from the Tel Aviv Stock Exchange